Eurofins Scientific announces the signing of an agreement to acquire Villapharma Research SL (“Villapharma”) in Spain. The transaction is expected to close in February 2017, upon fulfilment of customary closing conditions. Villapharma provides organic synthesis and medicinal chemistry servi ... more
Eurofins signs an agreement to acquire a majority stake in Nihon Kankyo
Eurofins Scientific has signed an agreement to acquire a 52.6% majority stake in Nihon Kankyo K.K. (Nihon Environmental Services, on 31 March 2012. The transaction is expected to be completed this week.
Nihon Kankyo K.K. was founded almost 40 years ago and is based in the greater Tokyo area. It generated revenues of over EUR 20m in 2011 and employs around 250 employees across 2 large laboratories and in several satellite offices serving the entire domestic Japanese market.
The acquisition allows Eurofins to complete its service offering in Japan and complements its existing activities in food and pharmaceutical testing, as Nihon has started developing testing offering for food and other products. Furthermore Nihon is one of the few environmental testing service providers with Radio Active Material Analysis (RMA) capabilities in Japan, complementing Eurofins' state-of-the-art high throughput laboratory for RMA for food and water in Tokyo and its global network of RMA laboratories in China, France and Germany.
“Nihon Kankyo K.K. is an excellent strategic fit to Eurofins’ existing activities in Japan, and provides a solid entry into the established domestic environmental testing market. Furthermore, it significantly reinforces the Group’s growing presence in the Asia Pacific region”, says Dr. Gilles Martin, CEO of Eurofins Scientific.
- laboratory services
Eurofins Scientific announces the acquisition of Megalab SA (“Megalab”), one of the top five clinical diagnostic laboratory groups in Spain, for approximately EUR 40m. Headquartered in Madrid, where the central laboratory is based, Megalab operates 83 sites, of which 35 are located in priva ... more
Viracor-IBT Laboratories Inc. (Viracor-IBT), a wholly-owned subsidiary of Eurofins Scientific (EUFI.PA), announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Zika Virus Real-time RT-PCR assay. Viracor-IBT will perform this ass ... more
- Carl Zeiss Meditec AG wins patent infringement action on trifocal intraocula ...
- Eurofins acquires VBM Laboratories in Denmark
- DURAN Group, WHEATON, and Kimble Unite to Form New Brand
- Analytik Jena enters Ultra-High Throughput Market
- analytica Vietnam 2017: More exhibitors and a strong supporting program